Brandes International ETF (BINV)
| Assets | $425.84M |
| Expense Ratio | 0.70% |
| PE Ratio | 14.96 |
| Shares Out | 10.35M |
| Dividend (ttm) | $0.89 |
| Dividend Yield | 2.17% |
| Ex-Dividend Date | Dec 30, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 32.40% |
| Volume | 20,455 |
| Open | 41.45 |
| Previous Close | 41.25 |
| Day's Range | 41.45 - 41.70 |
| 52-Week Low | 28.93 |
| 52-Week High | 41.70 |
| Beta | 0.37 |
| Holdings | 71 |
| Inception Date | Oct 3, 2023 |
About BINV
Fund Home PageThe Brandes International ETF (BINV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing in equity securities of companies who perform their business activities outside the US. The fund seeks securities that are perceived to be undervalued BINV was launched on Oct 3, 2023 and is issued by Brandes.
Top 10 Holdings
24.28% of assets| Name | Symbol | Weight |
|---|---|---|
| Alibaba Group Holding Limited | BABA | 2.99% |
| Takeda Pharmaceutical Company Limited | 4502 | 2.60% |
| Sanofi | SAN | 2.55% |
| GSK plc | GSK | 2.45% |
| JPMorgan U.S. Treasury Plus Money Market Fund | JTCXX | 2.42% |
| Petroleo Brasileiro SA Petrobras ADR | PJX.DE | 2.35% |
| STMicroelectronics N.V. | STMPA | 2.31% |
| Kering SA | PPRUY | 2.29% |
| Astellas Pharma Inc. | 4503 | 2.27% |
| BNP Paribas SA | BNPQY | 2.05% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.25321 | Dec 31, 2025 |
| Sep 29, 2025 | $0.12723 | Sep 30, 2025 |
| Jun 27, 2025 | $0.49497 | Jun 30, 2025 |
| Mar 28, 2025 | $0.01801 | Mar 31, 2025 |
| Dec 30, 2024 | $0.15784 | Dec 31, 2024 |
| Sep 27, 2024 | $0.10027 | Sep 30, 2024 |
Performance
BINV had a total return of 45.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 27.55%.
News
BINV: Brandes, The Iconic Value Stock Investor, In ETF Form
Brandes International might as well use the tag line "we buy ugly stocks." They are a deep contrarian value manager. The firm's success dates back to last century, and it investment success over the d...
Why Goldman Sachs is helping its clients launch ETFs
Firms should offer ETF products because investor demand is not slowing down, according to one Goldman Sachs ETF expert.
Hedge funds, family offices among those turning to Goldman Sachs ETF Accelerator
Goldman Sachs Group's recently created business designed to help firms quickly launch exchange-traded funds has more than just traditional asset managers as clients.